Objective to study the relationship between soluble tumor necrosis factor receptor (STNFR) 1, 2 and insulin resistance (IR).
目的了解血清可溶性肿瘤坏死因子受体(STNFR) 1,2与胰岛素抵抗(IR)的关系。
2
Conclusions STNFR might inhibit the bioactivity of TNF and decrease the body immunity. STNFR may be as a parameter in evaluating the severity and prognosis of disease.
结论STNFR抑制了TNF生物学活性而降低了机体的免疫功能，并可作为评估病情严重程度和预后的指标。
3
In addition, the reduced risk of developing colorectal tumors associated with regularly taking aspirin or NSAIDs was primarily seen among participants with high baseline sTNFR-2 levels.